A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19
Clinical trial NCT04411628 · COMPLETED
Trial details
- NCT number
- NCT04411628
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2020-08-26
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.